Details for New Drug Application (NDA): 021286

✉ Email this page to a colleague

NDA 021286 describes BENICAR, which is a drug marketed by Cosette and is included in two NDAs. It is available from one supplier. Additional details are available on the BENICAR profile page.

The generic ingredient in BENICAR is hydrochlorothiazide; olmesartan medoxomil. There are thirty-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; olmesartan medoxomil profile page.

Summary for 021286

Tradename:	BENICAR
Applicant:	Cosette
Ingredient:	olmesartan medoxomil
Patents:	0

Pharmacology for NDA: 021286

Mechanism of Action	Angiotensin 2 Receptor Antagonists

Medical Subject Heading (MeSH) Categories for 021286

Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents

Suppliers and Packaging for NDA: 021286

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
BENICAR	olmesartan medoxomil	TABLET;ORAL	021286	NDA	Cosette Pharmaceuticals, Inc.	0713-0860	0713-0860-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0860-30)
BENICAR	olmesartan medoxomil	TABLET;ORAL	021286	NDA	Cosette Pharmaceuticals, Inc.	0713-0861	0713-0861-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0861-30)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	5MG
Approval Date:	Apr 25, 2002	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	20MG
Approval Date:	Apr 25, 2002	TE:	AB	RLD:	Yes

Profile for product number 004

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	40MG
Approval Date:	Apr 25, 2002	TE:	AB	RLD:	Yes

Expired US Patents for NDA 021286

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Cosette	BENICAR	olmesartan medoxomil	TABLET;ORAL	021286-001	Apr 25, 2002	5,616,599*PED	⤷ Get Started Free
Cosette	BENICAR	olmesartan medoxomil	TABLET;ORAL	021286-004	Apr 25, 2002	6,878,703*PED	⤷ Get Started Free
Cosette	BENICAR	olmesartan medoxomil	TABLET;ORAL	021286-003	Apr 25, 2002	6,878,703*PED	⤷ Get Started Free
Cosette	BENICAR	olmesartan medoxomil	TABLET;ORAL	021286-004	Apr 25, 2002	5,616,599*PED	⤷ Get Started Free
Cosette	BENICAR	olmesartan medoxomil	TABLET;ORAL	021286-003	Apr 25, 2002	5,616,599*PED	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.